https://stke.sciencemag.org/content/8/404/ra119.long
“In mouse embryonic fibroblasts and primary mouse astrocytes, FKBP51 mediated several effects of paroxetine, namely, decreased the protein-protein interactions of DNMT1 with CDK5 and FKBP52, reduced phosphorylation of DNMT1, and decreased the methylation and increased the expression of the gene encoding brain-derived neurotrophic factor (Bdnf).”
Could this mean that FKBP51 is important for us (PSSD sufferers specifically)? There exist drugs that target this protein.